GenMark
Roche Diagnostics Q1 Sales Climb 50 Percent
The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year.
GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock
The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month.
Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.
Roche to Acquire GenMark Diagnostics for $1.8B
Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.
Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent
The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.
Feb 11, 2021
GenMark Shares Rise on Acquisition Rumors
May 4, 2020